Are retroperitoneal lymph node XXXX a major problem in @entity1204 ? Diagnostic and prognostic assessment with lymphography.

@entity1 @entity66 @entity3 @entity1204
The results of foot lymphography in 295 @entity1 with @entity1204 observed from 1968 to 1978 at two institutions are reported. One hundred and eighty-two were new cases, 61 were recurrences, and 52 were @entity1 who underwent restaging diagnostic procedures without clinical evidence of disease. The incidence of lymphatic spread was correlated with the clinical stage, the pathologic stage, and the extent of recurrent disease. In fact, in the 182 new cases, at clinical stage, the pathologic stage, lymphography was positive in 8.9% of @entity1 at Stage I, 28.6% at Stage II, 57.1% at Stage III, and 66.6% at Stage IV disease; at pathological stage, lymphography was positive in 8% of @entity1 at Stage I, 14.8% at Stage II, 39.3% at Stage II, and 53.3% at Stage IV disease. There was lymph node involvement in 47.5% of the 61 pretreated @entity1 . Finally, in 52 pretreated @entity1 with no evidence of disease, the incidence of lymph node involvement was 7.7%. In new cases, @entity3 were found only in the pelvic nodes in 56.2% of the @entity1 and only in the para-aortic nodes in 9.5%; in 34.3%, both chains were simultaneously involved. The five-year survival rate for @entity1 at Stage I, II, and @entity66 with positive lymphography was 35% as compared with 73% for negative cases. In @entity1 at Stage I and II, the difference of survival was equal to 24%. The reliability of the results is confirmed by the concordance with the data of the literature on histologic involvement, by the first radiologic-pathologic comparison, and by the clinical course of the positive cases. Lymphography is of unquestionable value for an appropriate staging and for a correct plan of treatment.
